DAYLI Partners

DAYLI Partners is a Seoul-based investment firm founded in 2014, active across venture capital, private equity and startup acceleration in South Korea. Its sector focus is concentrated on bio-healthcare - spanning life sciences and healthcare - and on financials-governance, areas the firm describes as industries undergoing structural change. The firm states its mission as supporting industry evolution and innovation through investment, and positions itself as a partner to businesses seeking growth and development.

The firm's operating scope has been built incrementally on licensed capability. It obtained a venture capital licence at incorporation in 2014, added private equity fund operations with a licence acquired in 2018, and secured an accelerator licence in 2019. It also operates as a programme operator for TIPS (Tech Incubator Program for Startups), the Korean government-backed incubation scheme, and for the Scale-up TIPS programme, extending its remit from investment into early-stage company building and later-stage scale support.

DAYLI Partners reports cumulative assets under management and a portfolio of current companies, though specific figures are not disclosed publicly. The firm's stated investment approach rests on specialist expertise in sectors in transition, applied across the company lifecycle from acceleration through venture and private equity stages. Further detail is available at dayli.partners.